Deep Track Capital’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$308M Buy
3,338,241
+538,241
+19% +$54M 5.04% 2
2025
Q4
$286M Sell
2,800,000
-1,354,086
-33% -$121M 5.1% 3
2025
Q3
$260M Sell
4,154,086
-95,914
-2% -$5.22M 7.24% 1
2025
Q2
$221M Sell
4,250,000
-1,193,721
-22% -$53.3M 7.09% 1
2025
Q1
$232M Sell
5,443,721
-975,845
-15% -$42.1M 7.51% 2
2024
Q4
$196M Buy
6,419,566
+419,006
+7% +$11.8M 7.32% 2
2024
Q3
$138M Buy
6,000,560
+1,500,560
+33% +$42.5M 4.37% 3
2024
Q2
$130M Sell
4,500,000
-1,500,000
-25% -$34.9M 3.88% 7
2024
Q1
$124M Buy
6,000,000
+1,000,000
+20% +$21.4M 3.55% 7
2023
Q4
$135M Buy
5,000,000
+950,000
+23% +$24.9M 4.52% 4
2023
Q3
$120M Buy
4,050,000
+2,550,000
+170% +$89.7M 4.63% 5
2023
Q2
$53.7M Buy
+1,500,000
New +$43.1M 2.49% 15

Other funds holding GH

Deep Track Capital's GH Position: Q1 2026 in Review

Deep Track Capital increased its Guardant Health (GH) stake by 19% in Q1 2026, buying an estimated $54M and bringing the position to 3,338,241 shares worth $308M. The position accounts for 5.04% of the portfolio, ranked #2.

Deep Track Capital first reported a position in GH in Q2 2023 and has held it in 12 quarters since. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Deep Track Capital held 3,338,241 shares of Guardant Health worth $308M as of Q1 2026.
  • Deep Track Capital bought 538,241 Guardant Health shares in Q1 2026, an estimated $54M.
  • Guardant Health made up 5.04% of Deep Track Capital's portfolio in Q1 2026, its #2 holding.
  • Deep Track Capital first reported a position in Guardant Health in Q2 2023 and has held it in 12 quarters since.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Deep Track Capital's 13F filing for Q1 2026, filed 15 May 2026.